CAR-T

Pharma

Solid tumor CAR-T, Pfizer-Innovent, China deals—Fierce Pharma Asia

CARsgen won the world's first approval for a solid tumor CAR-T. Pfizer and Innovent's $10 billion deal was formed within five months. Plus more China deals.

Angus Liu Jun 26, 2026 8:51am

CARsgen's gastric cancer CAR-T nabs world-first China approval

Jun 22, 2026 12:31pm

Gilead expanding access to Yescarta, Tecartus with Cencora deal

Jun 3, 2026 11:11am

Kyverna taps CCO as CAR-T autoimmune first comes into view

May 5, 2026 9:18am

With ‘lessons learned,’ Kite preps for key CAR-T launch

Apr 28, 2026 11:30am

Astellas, GSK-Hansoh, Daiichi—Fierce Pharma Asia

Apr 17, 2026 9:15am